Underarm antiperspirants/deodorants and breast cancer

Breast Cancer Research

Volumn 11, Issue SUPPL. 3, 2009, Pages

  Darbre, Philippa D ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPERSPIRANT AGENT; DEODORANT AGENT; ESTROGEN; ALUMINUM; MUTAGENIC AGENT; PHENOL DERIVATIVE;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CHEMICAL INTERACTION; DIETARY INTAKE; GENETIC SUSCEPTIBILITY; HORMONE SUBSTITUTION; HUMAN; NONHUMAN; AXILLA; BREAST CYST; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CHEMISTRY; FEMALE;

ALUMINUM; ANTIPERSPIRANTS; AXILLA; BREAST CYST; BREAST NEOPLASMS; FEMALE; HUMANS; MUTAGENS; PHENOLS;

EID: 77951882333     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2424     Document Type: Article

References (37)

1. Haagensen CD. Diseases of the Breast 1971, Philadelphia: WB Saunders, 2.
2. Darbre PD. Underarm cosmetics are a cause of breast cancer. Eur J Cancer Prev 2001, 10:389-393. 10.1097/00008469-200110000-00002, 11711753.
3. Darbre PD. Underarm cosmetics and breast cancer. J Appl Toxicol 2003, 23:89-95. 10.1002/jat.899, 12666152.
4. Darbre PD. Recorded quadrant incidence of female breast cancer in Great Britain suggests a disproportionate increase in the upper outer quadrant of the breast. Anticancer Res 2005, 25:2543-2550.
5. Darbre PD. Environmental oestrogens, cosmetics and breast cancer. Best Pract Res Clin Endocrinol Metab 2006, 20:121-143. 10.1016/j.beem.2005.09.007, 16522524.
6. Harvey PW, Darbre P. Endocrine disrupters and human health: could oestrogenic chemicals in bodycare cosmetics adversely affect breast cancer incidence in women? A review of evidence and call for further research. J Appl Toxicol 2004, 24:167-176. 10.1002/jat.978, 15211609.
7. Darbre PA, Harvey PW. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol 2008, 28:561-578. 10.1002/jat.1358, 18484575.
8. Laden K, Felger CB. Antiperspirants and Deodorants 1988, 7. New York: Marcel Dekker, [Cosmetic Science and Technology Series, edited by Jungermann E].
9. McGrath KG. An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/deodorants and underarm shaving. Eur J Cancer Prev 2003, 12:479-485. 10.1097/00008469-200312000-00006, 14639125.
10. Miller WR. Estrogen and Breast Cancer 1996, London: Chapman Hall.
11. Mirick DK, Davis S, Thomas DB. Antiperspirant use and the risk of breast cancer. J Natl Cancer Inst 2002, 94:1578-1580.
12. Darbre PD, Aljarrah A, Miller WR, Coldham NG, Sauer MJ, Pope GS. Concentrations of parabens in human breast tumours. J Appl Toxicol 2004, 24:5-13. 10.1002/jat.958, 14745841.
13. Janjua NR, Mogensen B, Andersson AM, Petersen JH, Henriksen M, Skakkebaek NE, Wulf HC. Systemic absorption of the sun-screens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene)camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol 2004, 123:57-61. 10.1111/j.0022-202X.2004.22725.x, 15191542.
14. Janjua NR, Mortensen GK, Andersson AM, Kongshoj B, Skakkebaek NE, Wulf HC. Systemic uptake of diethyl phthalate, dibutyl phthalate, and butyl paraben following whole-body topical application and reproductive and thyroid hormone levels in humans. Environ Sci Technol 2007, 41:5564-5570. 10.1021/es0628755, 17822133.
15. Janjua NR, Frederiksen H, Skakkebaek NE, Wulff HC, Andersson AM. Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans. Int J Androl 2008, 31:118-130. 10.1111/j.1365-2605.2007.00841.x, 18194284.
16. Janjua NR, Kongshoj B, Andersson AM, Wulff HC. Sunscreens in human plasma and urine after repeated whole-body topical application. J Eur Acad Dermatol Venereol 2008, 22:456-461. 10.1111/j.1468-3083.2007.02492.x, 18221342.
17. Finkelstein JS, McCully WF, MacLaughlin DT, Godine JE, Crowley WF. The Mortician's Mystery: gynecomastia and reversible hypogonadotropic hypogonadism in an embalmer. N Engl J Med 1988, 318:961-965.
18. Guarneri MP, Brambilla G, Liozzo A, Colombo I, Chiumello G. Estrogen exposure in a child from hair lotion used by her mother: clinical and hair analysis data. Clin Toxicol 2008, 46:762-764.
19. Komori S, Ito Y, Nakamura Y, Aoki M, Takashi T, Kinuta T, Tanaka H, Koyama K. A long-term user of cosmetic cream containing estrogen developed breast cancer and endometrial hyperplasia. Menopause 2008, 15:1191-1192. 10.1097/gme.0b013e318172847d, 18997588.
20. Rajapakse N, Silva E, Kortenkamp A. Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Perspect 2002, 110:917-921. 1240992, 12204827.
21. Wright JV, Schliesman B, Robinson L. Comparative measurements of serum estriol, estradiol, and estrone in non-pregnant, premenopausal women: a preliminary investigation. Alt Med Rev 1999, 4:266-270.
22. Russo J, Russo IH. Biology of disease. Biological and molecular bases of mammary carcinogenesis. Lab Invest 1987, 57:112-137.
23. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001, 2:133-140. 10.1016/S1470-2045(00)00254-0, 11902563.
24. Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert SM, Mittal MD, Hooke JA, Shriver CD. Outer breast quadrants demonstrate increased levels of genomic instability. Ann Surg Oncol 2004, 11:861-868. 10.1245/ASO.2004.03.024, 15313734.
25. Ellsworth DL, Ellsworth RE, Liebman MN, Hooke JA, Shriver CD. Genomic instability in histologically normal breast tissues: implications for carcinogenesis. Lancet Oncol 2004, 5:753-758. 10.1016/S1470-2045(04)01653-5, 15581548.
26. Exley C. Aluminium and Alzheimer's Disease: The Science that Describes the Link 2001, London: Elsevier.
27. Darbre PD. Aluminium, antiperspirants and breast cancer. J Inorg Biochem 2005, 99:1912-1919. 10.1016/j.jinorgbio.2005.06.001, 16045991.
28. Yiu G. Antiperspirant induced DNA damage in canine cells by Comet assay. Toxicol Mech Methods 2005, 15:25-28.
29. Flarend R, Bin T, Elmore D, Hem SL. A preliminary study of the dermal absorption of aluminium from antiperspirants using aluminium-26. Food Chem Toxicol 2001, 39:163-168. 10.1016/S0278-6915(00)00118-6, 11267710.
30. Exley C, Charles LM, Barr L, Martin C, Polwart A, Darbre PD. Aluminium in human breast tissue. J Inorg Biochem 2007, 101:1344-1346. 10.1016/j.jinorgbio.2007.06.005, 17629949.
31. Guillard O, Fauconneau B, Olichon D, Dedieu G, Delonche R. Hyperaluminemia in a woman using an aluminium-containing antiperspirant for 4 years. Am J Med 2004, 117:956-959. 10.1016/j.amjmed.2004.07.047, 15629736.
32. Yoshida K, Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci 2004, 95:866-871. 10.1111/j.1349-7006.2004.tb02195.x, 15546503.
33. Tryggvadottir L, Sigvaldason H, Olafsdottir H, Jonasson JG, Jonsson T, Tulinius H, Eyfjord JE. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. J Natl Cancer Inst 2006, 98:116-122.
34. Mannello F, Tonti GA, Darbre PD. Concentration of aluminium in breast cyst fluids collected from women affected by gross cystic breast disease. J Appl Toxicol 2009, 29:1-6. 10.1002/jat.1384, 18785682.
35. Byford JR, Shaw LE, Drew MG, Pope GS, Sauer MJ, Darbre PD. Oestrogenic activity of parabens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 2002, 80:49-60. 10.1016/S0960-0760(01)00174-1, 11867263.
36. Darbre PD, Byford JR, Shaw LE, Horton RA, Pope GS, Sauer MJ. Oestrogenic activity of isobutylparaben in vitro and in vivo. J Appl Toxicol 2002, 22:219-226. 10.1002/jat.860, 12210538.
37. Darbre PD, Byford JR, Shaw LE, Hall S, Coldham NG, Pope GS, Sauer MJ. Oestrogenic activity of benzylparaben. J Appl Toxicol 2003, 23:43-51. 10.1002/jat.886, 12518336.